News

Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the first-in-human (FIH) clinical trial for its 6/7 French FastSeal Bioabsorbable Vascular Access Closure System, achieving a 100 percent success rate throughout both phases of the clinical trial, with exceptional time to hemostasis (TTH) and time to ambulation (TTA).

Home December 10, 2012
Home
News

The U.S. Food and Drug Administration (FDA) is notifying healthcare professionals, caregivers and patients about a change to the container and carton labels for heparin products.

Home December 10, 2012
Home
Videos | Cardiac Imaging

Imaging Technology News experts discuss the trends and latest technology they saw on the show floor and in sessions at ...

Home December 07, 2012
Home
Videos | Antiplatelet and Anticoagulation Therapies

One-year results from the ADAPT-DES Trial were presented during TCT 2012. It examined patient hyporesponsiveness to ...

Home December 07, 2012
Home
Siemens, syngo.MR Cardiac 4-D, MRI software
Feature

Increasingly software applications are providing many of the major advancements in magnetic resonance imaging (MRI) rather than hardware. In recent years, this has translated into software that enables physicians to do more in less time, extract more diagnostic information from imaging exams and provide more accurate quantification. While a hospital may not spend millions to upgrade its MRI system, it frequently takes advantage of the lower cost option of other vendors’ software to assess and manipulate those images.

Home December 07, 2012
Home
Feature | Dave Fornell

Two key news items in September made me think about the future direction of hemodynamic support, and that intra-aortic balloon pumps (IABP) will increasingly face a more serious challenge from small percutaneous left ventricular assist devices (pLVAD). This was reinforced when I received a cardiology market analysis from GlobalData agreeing with this assessment.

Home December 07, 2012
Home
Feature | Dave Fornell

There were several evident trends on the show floor at RSNA 2012, including interest in software fueled by Stage 1 and 2 meaningful use requirements, new mammography solutions and innovations in imaging hardware.

Home December 07, 2012
Home
News

More than half of patients treated for claudication or critical limb ischemia (CLI) with stenting of the superficial femoral artery (SFA) had primary patency at five years, says a recent study.

Home December 07, 2012
Home
News

Featuring hovercraft-like C-arm movement and the unique Access Halo, the WorkRite technology on Toshiba America Medical Systems Inc.’s Infinix-i cardiovascular X-ray systems makes interventional procedures easier for clinicians and improves patient care.

Home December 07, 2012
Home
Tryton Side Branch Stent TRYTON Pivotal FDA IDE trial
Feature

Tryton Medical Inc. announced the completion of enrollment in the TRYTON Pivotal U.S. Food and Drug Administration (FDA) IDE trial evaluating the Tryton Side Branch Stent.

Home December 07, 2012
Home
News

Volcano Corporation announced that it has entered into a definitive agreement to acquire Sync-Rx Ltd., a privately-held company based in Israel that develops advanced software applications that optimize and facilitate transcatheter cardiovascular interventions using automated online image processing. It is anticipated the transaction will close within the next 30 days.

Home December 07, 2012
Home
Technology

December 6, 2012 — Neusoft Medical Systems Co. Ltd., a wholly owned subsidiary of Neusoft Corp., announced this week that its NeuViz 64 multi-slice computed tomography (CT) scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Home December 06, 2012
Home
News

December 6, 2012 — Daiichi Sankyo Inc. and Eli Lilly and Co. announced results of two retrospective studies comparing rates of readmission for subsequent heart attack and initial hospitalization costs among patients with acute coronary syndromes (ACS) treated with a percutaneous coronary intervention (PCI) and antiplatelet therapy.

Home December 06, 2012
Home
Technology

Giving clinicians a more complete picture while improving safety during interventional procedures, Toshiba America Medical Systems Inc. introduces Spot Fluoroscopy for its Infinix-i systems. Enabling quicker diagnoses and lower dose, clinicians can observe a target region of anatomy using Spot Fluoro’s live fluoroscopy while viewing the last image hold (LIH) surrounding area.

Home December 06, 2012
Home
Technology

The U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the HeartWare Ventricular Assist System (VAS) designed as a bridge to cardiac transplantation.

Home December 06, 2012
Home
Subscribe Now